Add like
Add dislike
Add to saved papers

Exploring the substrate specificity and catalytic mechanism of imidazolonepropionase (HutI) from Bacillus subtilis.

Imidazolonepropionase (HutI, EC 3.5.2.7) catalyzes the hydrolytic cleavage of carbon-nitrogen bond in 4-imidazolone-5-propionic acid (IPA) to yield l-formiminoglutamic acid, which is the third step in the universal histidine degradation pathway. In this article, using a combined quantum mechanics and molecular mechanics (QM/MM) approach, the specificity and catalytic mechanism of HutI from Bacillus subtilis have been explored by considering the four isomers of (S)- and (R)-enantiomers of IPA (S IPA-1,S IPA-2,R IPA-1 andR IPA-2). Our calculations reveal that the activation of hydrolytic water (a zinc-bound water) is performed by residue E252 via a "bridging" water molecule, which occurs before binding of the substrate. After the substrate binding, this activation channel is blocked by the substrate, and the other two residues (D324 and H272) cannot act as the general base to activate the hydrolytic water. For the two (S)-enantiomers of IPA, HutI can specifically convert one isomer of (S)-enantiomer (S IPA-1) to l-formiminoglutamic acid with an energy barrier of 16.6 kcal mol-1 . The conversion of another (S)-enantiomer (S IPA-2) corresponds to the energy barrier of 21.9 kcal mol-1 . However, for the two isomers of (R)-enantiomer,R IPA-1 corresponds to a higher energy barrier (21.8 kcal mol-1 ), andR IPA-2 is associated with a weak binding in the active site compared toS IPA-2. Thus, on the basis of our calculations,S IPA-1 is suggested to be the most favorable substrate for HutI, whereas the hydrolytic cleavage ofS IPA-2 may require a preliminary isomerization toS IPA-1.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app